查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607755

尼古丁口腔溶解性薄膜的全球市場:強度·給藥途徑·年齡層·銷售管道·不同地區的預測 (～2032年)

Global Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength, by Route of Administration, and by Age Group, by Sales Channel, and by Region Forecast till 2032
出版日期: | 出版商: Market Research Future | 英文 146 Pages | 訂單完成後即時交付

價格

全球尼古丁口溶薄膜市場規模預計將從2023年的1億美元成長到2024年的1.1億美元，預測期內複合年增長率為3.86%，預計2032年將達到1億美元。 5000 萬美元。

反吸煙力度不斷加大，推動了尼古丁口溶片的巨大需求，並以多種方式加速了市場成長。透過公共衛生運動和吸菸與健康辦公室 (OSH) 等政府舉措，積極鼓勵人們戒菸並減少尼古丁攝取。旨在減少菸草使用的計劃透過提供工具和資源來實施有效的戒菸策略來支持這些努力。

此外，口腔膜片（OTF）技術的優勢是推動全球尼古丁口腔可溶膜片市場的關鍵因素。 OTF 在口中快速溶解，無需水，使其成為一種簡單且便攜的尼古丁輸送方式。用戶可以隨時隨地謹慎使用。

區域洞察

北美市場預計將從 2023 年的 3,120 萬美元開始成長，預測期內複合年增長率為 3.86%。由於人們對戒菸輔助劑的認識不斷提高以及吸菸相關疾病盛行率的上升，北美尼古丁口服可溶薄膜市場正在迅速擴大。

歐洲尼古丁口腔溶解薄膜市場預計將從 2023 年的 4,448 萬美元開始成長，預測期內複合年增長率為 3.46%。由於尼古丁口溶膜的日益普及以及行業參與者的存在，歐洲尼古丁口溶膜市場預計在未來幾年將顯著成長。

預計亞太地區尼古丁口腔溶解薄膜市場在預測期內將以 4.77% 的複合年增長率成長，2023 年為 2,074 萬美元。由於中國、韓國、印度和日本等國家健康意識的提高、城市化和高吸煙率，該區域市場正在迅速擴大。

本報告提供全球尼古丁口腔溶解性薄膜的市場調查，彙整市場定義和概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

第3章 調查手法

第4章 市場動態

  • 促進因素
    • 加強戒菸與戒菸工作
    • 口腔膜劑的優點
  • 阻礙因素
    • 嚴格的監理政策
    • 尼古丁替代療法的存在
    • 尼古丁口腔膜劑產品的專利保護
  • 機會
    • 開始建造並啟動口腔膜生產
    • 與尼古丁口腔膜相關的創新

第5章 市場要素分析

  • 價值鏈分析
  • 波特五力分析
  • COVID-19 對全球尼古丁口服溶膠薄膜市場的影響
  • 尼古丁口溶薄膜包裝的質性訊息
  • 有關尼古丁口腔溶解薄膜最終用戶的定性訊息
  • 按地區劃分的價格分析

第6章 全球尼古丁口腔溶解性薄膜市場:強度

  • 概要
  • 1MG
  • 2MG
  • 其他

第7章 全球尼古丁口腔溶解性薄膜市場:各給藥途徑

  • 概要
  • 舌頭
  • 臉頰

第8章 全球尼古丁口腔溶解性薄膜市場:各年齡層)

  • 概要
  • 成人
  • 青年人

第9章 全球尼古丁口腔溶解性薄膜市場:各銷售管道

  • 概要
  • 線上
  • 離線

第10章 全球尼古丁口腔溶解性薄膜市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 其他地區
    • 南美
    • 中東·非洲

第11章 競爭情形

  • 市場佔有率分析
  • 競爭儀表板
  • 上市公司的股票概要
  • 比較分析:主要企業的財務
  • 主要的展開·成長策略

第12章 企業簡介

  • NICOCCINO HOLDING AB
  • NISSHA CO., LTD.
  • ADHEXPHARMA
  • ARX, LLC
  • ZIM LABORATORIES LIMITED
  • LTS LOHMANN THERAPIE-SYSTEME AG
  • NAL PHARMA
  • INVENTZ
  • RENEJIX PHARMA SOLUTIONS
  • DK LIVKON PVT. LTD

第13章 資料的引用

Product Code: MRFR/HC/26893-CR

Global Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength (1mg, 2mg, and Others), by Route of Administration (Tongue and Buccal), and by Age Group (Adults and Adolescents), by Sales Channel (Online and Offline), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032

Market Overview

The market for Nicotine Oral Dissolvable Thin Films was estimated to be worth USD 0.10 billion by 2023. The Nicotine Oral Dissolvable Thin Films Market is expected to increase from USD 0.11 billion in 2024 to USD 0.15 billion by 2032, with a compound yearly growth rate (CAGR) of 3.86% over the forecast period (2024-2032).

Significant demand for nicotine oral dissolvable thin films is being driven by growing efforts to quit smoking, which is accelerating market growth in a variety of ways. People are actively encouraged to quit smoking or reduce their nicotine consumption through public health campaigns and government initiatives, such as those run by the Office on Smoking and Health (OSH). Programs targeted at lowering tobacco use help in these efforts by providing tools and resources for implementing effective stop strategies.

Furthermore, the advantages of oral thin film (OTF) technology are important factors propelling the global nicotine oral dissolvable thin film market. Here are a few significant advantages that contribute to market expansion. OTFs dissolve quickly in the mouth and do not require water, making them a simple and portable form of nicotine delivery. Users can use them discreetly at any time and from any place.

Market Segment insights

The Nicotine Oral Dissolvable Thin Films Market is divided into three segments based on strength: 1mg, 2mg, and Others.

The Market has been divided into two sections based on the way of administration.

The Nicotine Oral Dissolvable Thin Films Market is divided into two age groups: adults and adolescents.

The market has been divided into two segments based on the sales channel: online and offline.

Regional insights

The North America Nicotine Oral Dissolvable Thin Films Market was worth USD 31.20 million in 2023, and it is expected to increase at a CAGR of 3.86% over the forecast period. North America is further divided into the United States and Canada. The North American nicotine oral dissolvable thin films market is expanding rapidly, driven by increased awareness of smoking cessation aids and the rising prevalence of smoking-related health conditions.

The Europe Nicotine Oral Dissolvable Thin Films Market was worth USD 44.48 million in 2023, and it is expected to increase at a CAGR of 3.46% over the forecast period. The European nicotine oral dissolvable thin films market is expected to increase significantly in the coming years, owing to the increasing popularity of nicotine oral dissolvable thin films and the existence of industry players.

The Asia-Pacific Nicotine Oral Dissolvable Thin Films Market was worth USD 20.74 million in 2023, and it is expected to increase at a CAGR of 4.77% over the forecast period. The Asia-Pacific nicotine oral dissolvable thin films market is expanding rapidly due to rising health awareness, urbanization, and high smoking rates in countries such as China, South Korea, India, and Japan.

Major Players

Nicoccino Holding AB (Japan), AdhexPharma (France), ARx, LLC (US), ZIM Laboratories Limited (India), LTS Lohmann Therapie-Systeme AG (Germany), NAL Pharma (China), INVENTZ Lifesciences (India), Renejix Pharma Solutions (US), and DK Livkon Healthcare Pvt. Ltd. (India) are among the market's key players.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING SMOKING AND TOBACCO CESSATION EFFORTS
    • 4.2.2 ADVANTAGE OF ORAL THIN FILM DRIVES THE MARKET GROWTH
  • 4.3 RESTRAINTS
    • 4.3.1 STRINGENT REGULATORY POLICIES
    • 4.3.2 PRESENCE OF NICOTINE REPLACEMENT THERAPIES
    • 4.3.3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS
  • 4.4 OPPORTUNITY
    • 4.4.1 INITIATION TO BUILD AND LAUNCH ORAL THIN FILM MANUFACTURING
    • 4.4.2 INNOVATION ASSOCIATED WITH NICOTINE ORAL THIN FILM

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION & SALES
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET
  • 5.4 QUALITATIVE INFORMATION ON PACKAGING OF NICOTINE ORAL DISSOLVABLE THIN FILMS
    • 5.4.1 PACKAGING MATERIALS
      • 5.4.1.1 FOIL, PAPER, OR PLASTIC POUCHES
      • 5.4.1.2 SINGLE POUCH AND ALUMINUM POUCH
      • 5.4.1.3 BLISTER CARD WITH MULTIPLE UNITS
      • 5.4.1.4 BARRIER FILMS
    • 5.4.2 LABELING AND INFORMATION FOR NICOTINE ORAL DISSOLVABLE THIN FILMS
      • 5.4.2.1 REGULATORY COMPLIANCE
      • 5.4.2.2 NICOTINE DOSAGE
      • 5.4.2.3 WARNINGS AND PRECAUTIONS
      • 5.4.2.4 EXPIRATION DATES
  • 5.5 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS
    • 5.5.1 CHALLENGES IN FORMULATION, STABILITY, AND MANUFACTURING OF ORAL THIN FILM (OTF)
    • 5.5.2 STRINGENT REGULATORY POLICIES FOR THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET
  • 5.6 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS
    • 5.6.1 SMOKERS & EX-SMOKERS
    • 5.6.2 CONVENIENCE AND DISCREET USE
  • 5.7 PRICING ANALYSIS, BY REGION 2023 (USD)

6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH

  • 6.1 OVERVIEW
  • 6.2 1MG
  • 6.3 2MG
  • 6.4 OTHERS

7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION

  • 7.1 OVERVIEW
  • 7.2 TONGUE
  • 7.3 BUCCAL

8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP

  • 8.1 OVERVIEW
  • 8.2 ADULTS
  • 8.3 ADOLESCENTS

9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL

  • 9.1 OVERVIEW
  • 9.2 ONLINE
  • 9.3 OFFLINE

10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 US
    • 10.2.2 CANADA
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 FRANCE
    • 10.3.3 UK
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 CHINA
    • 10.4.2 INDIA
    • 10.4.3 JAPAN
    • 10.4.4 SOUTH KOREA
    • 10.4.5 AUSTRALIA
    • 10.4.6 REST OF ASIA-PACIFIC
  • 10.5 REST OF THE WORLD
    • 10.5.1 LATIN AMERICA
    • 10.5.2 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET SHARE ANALYSIS,
  • 11.3 COMPETITOR DASHBOARD
  • 11.4 PUBLIC PLAYERS STOCK SUMMARY
  • 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.6.1 AGREEMENT
    • 11.6.2 EXPANSION
    • 11.6.3 PRODUCT APPROVAL
    • 11.6.4 PRODUCT RECOGNITION

12 COMPANY PROFILES

  • 12.1 NICOCCINO HOLDING AB
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS OFFERED
    • 12.1.4 ADDITIONAL INFORMATION
    • 12.1.5 KEY DEVELOPMENTS
    • 12.1.6 SWOT ANALYSIS
    • 12.1.7 KEY STRATEGIES
  • 12.2 NISSHA CO., LTD.
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS OFFERED
    • 12.2.4 ADDITIONAL INFORMATION
    • 12.2.5 KEY DEVELOPMENTS
    • 12.2.6 SWOT ANALYSIS
    • 12.2.7 KEY STRATEGIES
  • 12.3 ADHEXPHARMA
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCT OFFERED
    • 12.3.4 ADDITIONAL INFORMATION
    • 12.3.5 KEY DEVELOPMENTS
    • 12.3.6 KEY STRATEGIES
  • 12.4 ARX, LLC
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS OFFERED
    • 12.4.4 ADDITIONAL INFORMATION
    • 12.4.5 KEY DEVELOPMENTS
    • 12.4.6 KEY STRATEGIES
  • 12.5 ZIM LABORATORIES LIMITED
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS OFFERED
    • 12.5.4 ADDITIONAL INFORMATION
    • 12.5.5 KEY DEVELOPMENTS
    • 12.5.6 SWOT ANALYSIS
    • 12.5.7 KEY STRATEGIES
  • 12.6 LTS LOHMANN THERAPIE-SYSTEME AG
    • 12.6.1 COMPANY OVERVIEW
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS OFFERED
    • 12.6.4 ADDITIONAL INFORMATION
    • 12.6.5 KEY DEVELOPMENTS
    • 12.6.6 SWOT ANALYSIS
    • 12.6.7 KEY STRATEGIES
  • 12.7 NAL PHARMA
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS OFFERED
    • 12.7.4 ADDITIONAL INFORMATION
    • 12.7.5 KEY DEVELOPMENTS
    • 12.7.6 KEY STRATEGIES
  • 12.8 INVENTZ
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS OFFERED
    • 12.8.4 ADDITIONAL INFORMATION
    • 12.8.5 KEY DEVELOPMENTS
    • 12.8.6 SWOT ANALYSIS
    • 12.8.7 KEY STRATEGIES
  • 12.9 RENEJIX PHARMA SOLUTIONS
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 SERVICES OFFERED
    • 12.9.4 ADDITIONAL INFORMATION
    • 12.9.5 KEY DEVELOPMENTS
    • 12.9.6 KEY STRATEGIES
  • 12.10 DK LIVKON PVT. LTD
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 SERVICES OFFERED
    • 12.10.4 ADDITIONAL INFORMATION
    • 12.10.5 KEY DEVELOPMENTS
    • 12.10.6 KEY STRATEGIES

13 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 ADVANTAGE OF ORAL THIN FILM
  • TABLE 3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS
  • TABLE 4 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 1MG, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 2MG, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR TONGUE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR BUCCAL, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADULTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADOLESCENTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ONLINE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OFFLINE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 19 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 20 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 21 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 22 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 23 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 24 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 25 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 26 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 27 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 28 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 29 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 30 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 31 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 1 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 2 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 3 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 4 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 5 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 6 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 7 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 8 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 9 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 10 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 11 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 12 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 13 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 14 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 15 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 16 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 17 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 18 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 19 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 20 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 21 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 22 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 23 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 24 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 25 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 26 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 27 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 28 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 1 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 2 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 3 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 4 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 5 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 6 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 7 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 8 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 9 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 10 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 11 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 12 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 13 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 14 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 15 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 16 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 17 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 18 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 19 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 20 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 21 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 22 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 23 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 24 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 1 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 2 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 3 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 4 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 5 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 1 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 2 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 3 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 4 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 5 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 6 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 7 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 8 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 9 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 10 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 11 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 12 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 13 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 14 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 15 AGREEMEENT
  • TABLE 16 EXPANSION
  • TABLE 17 PRODUCT APPROVAL
  • TABLE 18 PRODUCT RECOGNITION
  • TABLE 19 NICOCCINO HOLDING AB: PRODUCTS OFFERED
  • TABLE 20 NICOCCINO HOLDING AB: ADDITIONAL INFORMATION
  • TABLE 21 NISSHA CO., LTD.: PRODUCTS OFFERED
  • TABLE 22 NISSHA CO., LTD.: ADDITIONAL INFORMATION
  • TABLE 23 ADHEXPHARMA: PRODUCTS OFFERED
  • TABLE 24 ADHEXPHARMA: ADDITIONAL INFORMATION
  • TABLE 25 ARX, LLC: PRODUCTS OFFERED
  • TABLE 26 ARX, LLC: ADDITIONAL INFORMATION
  • TABLE 27 ZIM LABORATORIES LIMITED: PRODUCTS OFFERED
  • TABLE 28 ZIM LABORATORIES LIMITED: ADDITIONAL INFORMATION
  • TABLE 29 ZIM LABORATORIES LIMITED: KEY DEVELOPMENTS
  • TABLE 30 LTS LOHMANN THERAPIE-SYSTEME AG: PRODUCTS OFFERED
  • TABLE 31 LTS LOHMANN THERAPIE-SYSTEME AG: ADDITIONAL INFORMATION
  • TABLE 32 NAL PHARMA: PRODUCTS OFFERED
  • TABLE 33 ADDITIONAL INFORMATION
  • TABLE 34 INVENTZ: PRODUCTS OFFERED
  • TABLE 35 INVENTZ: ADDITIONAL INFORMATION
  • TABLE 36 RENEJIX PHARMA SOLUTIONS: SERVICES OFFERED
  • TABLE 37 RENEJIX PHARMA SOLUTIONS: ADDITIONAL INFORMATION
  • TABLE 38 DK LIVKON PVT. LTD: SERVICES OFFERED
  • TABLE 39 DK LIVKON PVT. LTD: ADDITIONAL INFORMATION

LIST OF FIGURES

  • FIGURE 1 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: STRUCTURE
  • FIGURE 2 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 VALUE CHAIN ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET
  • FIGURE 6 MANUFACTURING PROCESS FOR THE NICOTINE ORAL DISSOLVABLE THIN FILM
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET
  • FIGURE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, STRENGTH SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY STRENGTH,
  • FIGURE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, ROUTE OF ADMINISTRATION SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2023 & 2032 (USD MILLION)
  • FIGURE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY ROUTE OF ADMINISTRATION,
  • FIGURE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, AGE GROUP SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2023 & 2032 (USD MILLION)
  • FIGURE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY AGE GROUP,
  • FIGURE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, SALES CHANNEL SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 18 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2023 & 2032 (USD MILLION)
  • FIGURE 19 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY SALES CHANNEL,
  • FIGURE 20 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 21 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION,
  • FIGURE 22 NORTH AMERICA MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 23 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 24 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 25 EUROPE MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 26 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 27 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION,
  • FIGURE 28 ASIA-PACIFIC MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 30 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 31 REST OF THE WORLD MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 32 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 33 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION,
  • FIGURE 34 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 35 COMPETITOR DASHBOARD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET
  • FIGURE 36 NICOCCINO HOLDING AB: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 37 NICOCCINO HOLDING AB: SWOT ANALYSIS
  • FIGURE 38 NISSHA CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 NISSHA CO., LTD.: SWOT ANALYSIS
  • FIGURE 40 ZIM LABORATORIES LIMITED: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 ZIM LABORATORIES LIMITED: SWOT ANALYSIS
  • FIGURE 42 LTS LOHMANN THERAPIE-SYSTEME AG: SWOT ANALYSIS
  • FIGURE 43 INVENTZ: SWOT ANALYSIS